Clayton Russell — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Clayton Russell is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.

Profile

Russell Clayton is the Chief Medical Officer of Larimar Therapeutics, Inc. Based on the SEC filing context, he serves as the chief medical officer responsible for clinical development and medical affairs for Larimar's therapeutic programs, including CTI-1601 for Friedreich's ataxia.

Board memberships

• Larimar Therapeutics, Inc.

Awards & honors

• Led medical strategy for CTI-1601 preclinical/clinical development
• Oversaw medical affairs for rare-disease programs
• Contributed to regulatory planning and strategy

Recent Transactions

Frequently Asked Questions

Who is Clayton Russell?

Russell Clayton is the Chief Medical Officer of Larimar Therapeutics, Inc. Based on the SEC filing context, he serves as the chief medical officer responsible for clinical development and medical affairs for Larimar's therapeutic programs, including CTI-1601 for Friedreich's ataxia.…

Where can I see all of Clayton Russell's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week